TexCAPS


Also found in: Acronyms.

TexCAPS

Cardiology A clinical trial–Texas Coronary Atherosclerosis Prevention Study
Mentioned in ?
References in periodicals archive ?
Nearly all of the clinical benefit in terms of reduced event rates in AFCAPS / TexCAPS occurred in patients in the lowest third of HDL distribution at baseline, those with an HDL below 34 mg/dL.
In a hypothesis-generating analysis of the AFCAPS/ TexCAPS trial published in 2001, lovastatin was found to benefit those with low LDL-C and high hsCRP, whereas no benefit was observed in low LDL-C, low hsCRP patients (10).
People in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/ TexCAPS) were most likely to have benefit from lovastatin if they had elevated CRP.